View in EDS HTML Full Text PDF Full Text

Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.

Saved in:
Bibliographic Details
Title: Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.
Authors: Amgad M; 1Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA., Stovgaard ES; 2Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Balslev E; 2Department of Pathology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev, Denmark., Thagaard J; 3DTU Compute, Department of Applied Mathematics, Technical University of Denmark, Lyngby, Denmark.; Visiopharm A/S, Hørsholm, Denmark., Chen W; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA., Dudgeon S; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA., Sharma A; 1Department of Biomedical Informatics, Emory University School of Medicine, Atlanta, GA USA., Kerner JK; 6PathAI, Cambridge, MA USA., Denkert C; 7Institut für Pathologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Philipps-Universität Marburg, Marburg, Germany.; 8Institute of Pathology, Philipps-University Marburg, Marburg, Germany.; German Cancer Consortium (DKTK), Partner Site Charité, Berlin, Germany., Yuan Y; 10Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; 11Division of Molecular Pathology, The Institute of Cancer Research, London, UK., AbdulJabbar K; 10Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; 11Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Wienert S; 7Institut für Pathologie, Universitätsklinikum Gießen und Marburg GmbH, Standort Marburg, Philipps-Universität Marburg, Marburg, Germany., Savas P; 12Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia.; 13Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Voorwerk L; 14Department of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Beck AH; 6PathAI, Cambridge, MA USA., Madabhushi A; 15Case Western Reserve University, Department of Biomedical Engineering, Cleveland, OH USA.; 16Louis Stokes Cleveland Veterans Administration Medical Center, Cleveland, OH USA., Hartman J; 17Department of Oncology and Pathology, Karolinska Institutet and University Hospital, Solna, Sweden., Sebastian MM; 18Departments of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Horlings HM; 19Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Hudeček J; 20Department of Research IT, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ciompi F; 21Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands., Moore DA; 22Department of Pathology, UCL Cancer Institute, London, UK., Singh R; 23Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, NY USA., Roblin E; 24Université Paris-Saclay, Univ. Paris-Sud, Villejuif, France., Balancin ML; 25Department of Pathology, Faculty of Medicine, University of São Paulo, São Paulo, Brazil., Mathieu MC; 26Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, France., Lennerz JK; 27Department of Pathology, Massachusetts General Hospital, Boston, MA USA., Kirtani P; Department of Histopathology, Manipal Hospitals Dwarka, New Delhi, India., Chen IC; 29Department of Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Braybrooke JP; 30Nuffield Department of Population Health, University of Oxford, Oxford, UK.; 31Department of Medical Oncology, University Hospitals Bristol NHS Foundation Trust, Bristol, UK., Pruneri G; 32Pathology Department, Fondazione IRCCS Istituto Nazionale Tumori and University of Milan, School of Medicine, Milan, Italy., Demaria S; 33Weill Cornell Medical College, New York, NY USA., Adams S; 34Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY USA., Schnitt SJ; 35Department of Pathology, Brigham and Women's Hospital, Boston, MA USA., Lakhani SR; 36The University of Queensland Centre for Clinical Research and Pathology Queensland, Brisbane, Australia., Rojo F; 37Pathology Department, CIBERONC-Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.; 38GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain., Comerma L; 37Pathology Department, CIBERONC-Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.; 38GEICAM-Spanish Breast Cancer Research Group, Madrid, Spain., Badve SS; 39Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN USA., Khojasteh M; Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA USA., Symmans WF; 41Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Sotiriou C; 42Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Université Libre de Bruxelles (ULB), Brussels, Belgium.; 43ULB-Cancer Research Center (U-CRC) Université Libre de Bruxelles, Brussels, Belgium., Gonzalez-Ericsson P; 44Breast Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN USA., Pogue-Geile KL; NRG Oncology/NSABP, Pittsburgh, PA USA., Kim RS; NRG Oncology/NSABP, Pittsburgh, PA USA., Rimm DL; 46Department of Pathology, Yale University School of Medicine, New Haven, CT USA., Viale G; 47Department of Pathology, IEO, European Institute of Oncology IRCCS & State University of Milan, Milan, Italy., Hewitt SM; 48Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD USA., Bartlett JMS; 49Ontario Institute for Cancer Research, Toronto, ON Canada.; 50Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK., Penault-Llorca F; 51Department of Pathology and Molecular Pathology, Centre Jean Perrin, Clermont-Ferrand, France.; 52UMR INSERM 1240, Universite Clermont Auvergne, Clermont-Ferrand, France., Goel S; 53Victorian Comprehensive Cancer Centre building, Peter MacCallum Cancer Centre, Melbourne, Victoria Australia., Lien HC; 54Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan., Loibl S; 55German Breast Group, c/o GBG-Forschungs GmbH, Neu-Isenburg, Germany., Kos Z; Department of Pathology, BC Cancer, Vancouver, British Columbia Canada., Loi S; 13Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.; 57Peter MacCallum Cancer Centre, Melbourne, Australia., Hanna MG; 58Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY USA., Michiels S; 59Gustave Roussy, Universite Paris-Saclay, Villejuif, France.; 60Université Paris-Sud, Institut National de la Santé et de la Recherche Médicale, Villejuif, France., Kok M; 61Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; 62Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Nielsen TO; 63University of British Columbia, Vancouver, British Columbia Canada., Lazar AJ; 41Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 64Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 65Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX USA.; 66Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX USA., Bago-Horvath Z; 67Department of Pathology, Medical University of Vienna, Vienna, Austria., Kooreman LFS; 68GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, The Netherlands.; 69Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands., van der Laak JAWM; 21Department of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.; 70Center for Medical Image Science and Visualization, Linköping University, Linköping, Sweden., Saltz J; 71Department of Biomedical Informatics, Stony Brook University, Stony Brook, NY USA., Gallas BD; FDA/CDRH/OSEL/Division of Imaging, Diagnostics, and Software Reliability, Silver Spring, MD USA., Kurkure U; Roche Tissue Diagnostics, Digital Pathology, Santa Clara, CA USA., Barnes M; Roche Diagnostics Information Solutions, Belmont, CA USA., Salgado R; 12Division of Research and Cancer Medicine, Peter MacCallum Cancer Centre, University of Melbourne, Victoria, Australia.; Department of Pathology, GZA-ZNA Ziekenhuizen, Antwerp, Belgium., Cooper LAD; 74Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL USA.
Corporate Authors: International Immuno-Oncology Biomarker Working Group
Source: NPJ breast cancer [NPJ Breast Cancer] 2020 May 12; Vol. 6, pp. 16. Date of Electronic Publication: 2020 May 12 (Print Publication: 2020).
Publication Type: Journal Article; Review
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: eCollection Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2374-4677
DOI:10.1038/s41523-020-0154-2